[Federal Register Volume 63, Number 122 (Thursday, June 25, 1998)]
[Notices]
[Pages 34651-34652]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-16752]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30DAY-16-98]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-7090. Send written
comments to CDC, Desk Officer; Human Resources and Housing Branch, New
Executive Office Building, Room 10235; Washington, DC 20503. Written
comments should be received within 30 days of this notice.
Proposed Projects
1. Breast Cancer Incidence in an Occupational Cohort Exposed to
Ethylene Oxide and in an Occupational Cohort Exposed to Polychlorinated
Biphenyls (0920-0366)--National Institute for Occupational Safety and
Health (NIOSH)--Extension--Breast cancer is the most common incident
cancer among U.S. women, and the second leading cause of cancer
mortality in U.S. women. Increasing numbers of women are employed
outside the home, yet few studies of breast cancer etiology have
addressed occupational and environmental chemical exposures, and
[[Page 34652]]
many cancer studies of industrial cohorts have excluded women. This
study will provide information concerning: (1) the incidence of breast
cancer in a cohort of women exposed to ethylene oxide (ETO), and (2)
the incidence of breast cancer in a cohort of women exposed to
polychlorinated biphenyls (PCBs). Both compounds are suspected breast
carcinogens. These two cohorts have been previously assembled by NIOSH,
and each represents the largest and best defined female study cohort in
the U.S. for the respective exposure.
All women in the existing NIOSH ethylene oxide cohort (n=9,929) and
PCB cohort (13,736) will be enrolled in the study. For both cohorts,
data from personnel records has been coded into a computer file
containing demographic, and work history information. This information
will be used to estimate workplace exposures. Vital status has been
determined through automated data sources. Questionnaires are currently
being mailed to each living cohort member to obtain information on
breast cancer incidence and risk factors for breast cancer. For
deceased cohort members, next-of-kin will be asked to provide this
information. Other record sources such as death certificates and
population-based cancer incidence registries will also be used to
identify cancer cases. The diagnosis will be confirmed by medical
records. Each questionnaire will take approximately 30 minutes to
complete. Total annual burden hours are 12,500.
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden/ Total
Respondents Number of responses/ response burden (in
respondents respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
Workers..................................................... 23,000 1 .50 11,500
Medical providers........................................... 2,000 1 .50 1,000
----------------------------------------------------------------------------------------------------------------
2. Tests and Requirements for Certification and Approval of
Respiratory Protective Devices--42 CFR 84--Regulation--(0920-0109)--
Extension--The regulatory authority for the National Institute for
Occupational Safety and Health (NIOSH) certification program for
respiratory protective devices is found in the Mine Safety and Health
Amendments Act of 1977 (30 U.S.C. 577a, 651 et seq., and 657(g)) and
the Occupational Safety and Health Act of 1970 (30 U.S.C. 3, 5, 7, 811,
842(h), 844). These regulations have, as their basis, the performance
tests and criteria for approval of respirators used by millions of
American construction workers, miners, painters, asbestos removal
workers, fabric mill workers, and fire fighters. In addition to
benefitting industrial workers, the improved testing requirements also
benefit health care workers implementing the current CDC Guidelines for
Preventing the Transmission of Tuberculosis. Regulations of the
Environmental Protection Agency (EPA) and the Nuclear Regulatory
Commission (NRC) also require the use of NIOSH-approved respirators.
NIOSH, in accordance with implementing regulations 42 CFR 84: (1)
Issues certificates of approval for respirators which have met improved
construction, performance, and protection requirements; (2) establishes
procedures and requirements to be met in filing applications for
approval; (3) specifies minimum requirements and methods to be employed
by NIOSH and by applicants in conducting inspections, examinations, and
tests to determine effectiveness of respirators; (4) establishes a
schedule of fees to be charged applicants for testing and
certification, and (5) establishes approval labeling requirements.
Total annual burden hours are 177,968.
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden/ Total
Respondents (section/data type) respondents responses/ response burden (in
respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
84.11/Applications.......................................... 56 14.0 63.56 49,831
84.33/Labeling.............................................. 56 14.0 1.54 1,207
84.35/Modifications......................................... 56 14.0 79.45 62,289
84.41/Reporting............................................. 56 14.0 22.70 17,797
84.43/Record keeping........................................ 56 14.0 56.75 44,492
84.257/Labeling............................................. 56 14.0 1.50 1,176
84.1103/Labeling............................................ 56 14.0 1.50 1,176
----------------------------------------------------------------------------------------------------------------
Dated: June 18, 1998.
Charles W. Gollmar,
Acting Associate Director for Policy Planning and Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 98-16752 Filed 6-24-98; 8:45 am]
BILLING CODE 4163-18-P